SCYNEXIS, Inc. Payments to Acquire Held-to-maturity Securities
SCYNEXIS, Inc. (SCYX) reported Payments to Acquire Held-to-maturity Securities of $39.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2026-08-10
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for the quarter ending 2026-06-30 was $36.21M.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for the quarter ending 2026-03-31 was $3.27M.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for the quarter ending 2025-12-31 was $18.90M, a 124.18% increase year-over-year.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for fiscal 2025 was $18.90M, a 48.09% decline from fiscal 2024.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for fiscal 2024 was $36.42M, a 57.40% decline from fiscal 2023.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for fiscal 2023 was $85.48M, a 212.20% increase from fiscal 2022.
- SCYNEXIS, Inc. payments to acquire held-to-maturity securities for fiscal 2022 was $27.38M.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $39.49M 10-Q · filed 2026-08-10 | $58.39M derived: sum of 3 quarters · filed 2026-08-10 | $58.39M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $3.27M 10-Q · filed 2026-05-11 | $22.18M derived: sum of 2 quarters · filed 2026-05-11 | $22.18M derived: sum of 3 quarters · filed 2026-05-11 | $22.18M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $18.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $18.90M derived: sum of 2 quarters · filed 2026-03-04 | $18.90M derived: sum of 3 quarters · filed 2026-08-10 | $18.90M 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2025-11-05 | $8.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $8.43M derived: sum of 3 quarters · filed 2026-08-10 | $25.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $8.43M derived: sum of 2 quarters · filed 2026-05-11 | $25.70M derived: sum of 3 quarters · filed 2026-05-11 | $33.91M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $25.70M derived: sum of 2 quarters · filed 2026-03-04 | $33.91M derived: sum of 3 quarters · filed 2026-03-04 | $36.42M 10-K · filed 2026-03-04 |
| 2024-09-30 | $17.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $25.48M derived: sum of 2 quarters · filed 2025-11-05 | $27.98M 10-Q · filed 2025-11-05 | $40.19M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $8.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $10.72M 10-Q · filed 2025-08-13 | $22.92M derived: sum of 3 quarters · filed 2025-08-13 | $69.26M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.51M 10-Q · filed 2025-05-15 | $14.71M derived: sum of 2 quarters · filed 2025-05-15 | $61.05M derived: sum of 3 quarters · filed 2025-05-15 | $87.99M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $12.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $58.54M derived: sum of 2 quarters · filed 2025-03-12 | $85.48M derived: sum of 3 quarters · filed 2025-03-12 | $85.48M 10-K · filed 2025-03-12 |
| 2023-09-30 | $46.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $73.28M derived: sum of 2 quarters · filed 2024-11-06 | $73.28M 10-Q · filed 2024-11-06 | $73.28M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $26.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $26.94M 10-Q · filed 2024-08-08 | $26.94M derived: sum of 3 quarters · filed 2024-08-08 | $54.32M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | $27.38M derived: sum of 3 quarters · filed 2024-05-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $27.38M derived: sum of 2 quarters · filed 2024-03-28 | $27.38M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $27.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $27.38M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $0.00 derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $0.00 derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $14.23M 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $14.23M 10-Q · filed 2021-11-10 | $15.23M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $14.23M 10-Q · filed 2021-08-16 | $15.23M derived: sum of 3 quarters · filed 2021-08-16 | $27.15M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $14.23M 10-Q · filed 2021-05-17 | $15.23M derived: sum of 2 quarters · filed 2021-05-17 | $27.15M derived: sum of 3 quarters · filed 2021-05-17 | $35.69M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $996.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $12.91M derived: sum of 2 quarters · filed 2021-03-29 | $21.46M derived: sum of 3 quarters · filed 2021-03-29 | $39.50M 10-K · filed 2021-03-29 |
| 2019-09-30 | $11.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $20.46M derived: sum of 2 quarters · filed 2020-11-06 | $38.50M 10-Q · filed 2020-11-06 | $61.65M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $8.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $26.59M 10-Q · filed 2020-08-10 | $49.73M derived: sum of 3 quarters · filed 2020-08-10 | $65.61M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $18.04M 10-Q · filed 2020-05-11 | $41.19M derived: sum of 2 quarters · filed 2020-05-11 | $57.07M derived: sum of 3 quarters · filed 2020-05-11 | $87.18M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $23.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $39.03M derived: sum of 2 quarters · filed 2020-03-11 | $69.14M derived: sum of 3 quarters · filed 2020-03-11 | $85.11M 10-K · filed 2020-03-11 |
| 2018-09-30 | $15.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $45.99M derived: sum of 2 quarters · filed 2019-11-12 | $61.96M 10-Q · filed 2019-11-12 | $78.84M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $30.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $46.08M 10-Q · filed 2019-08-07 | $62.96M derived: sum of 3 quarters · filed 2019-08-07 | $79.90M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $15.97M 10-Q · filed 2019-05-08 | $32.85M derived: sum of 2 quarters · filed 2019-05-08 | $49.79M derived: sum of 3 quarters · filed 2019-05-08 | $76.25M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $16.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $33.81M derived: sum of 2 quarters · filed 2019-03-14 | $60.28M derived: sum of 3 quarters · filed 2019-03-14 | $78.44M 10-K · filed 2019-03-14 |
| 2017-09-30 | $16.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $43.40M derived: sum of 2 quarters · filed 2018-11-13 | $61.56M 10-Q · filed 2018-11-13 | $61.60M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $26.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $44.62M 10-Q · filed 2018-08-09 | $44.66M derived: sum of 3 quarters · filed 2018-08-09 | $67.69M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $18.16M 10-Q · filed 2018-05-08 | $18.20M derived: sum of 2 quarters · filed 2018-05-08 | $41.23M derived: sum of 3 quarters · filed 2018-05-08 | $53.71M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $23.07M derived: sum of 2 quarters · filed 2018-03-13 | $35.55M derived: sum of 3 quarters · filed 2018-03-13 | $35.55M 10-K · filed 2018-03-13 |
| 2016-09-30 | $23.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $35.51M derived: sum of 2 quarters · filed 2017-11-07 | $35.51M 10-Q · filed 2017-11-07 | $35.51M derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | $12.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $12.47M 10-Q · filed 2017-08-08 | $12.47M derived: sum of 3 quarters · filed 2017-08-08 | $12.47M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | $0.00 derived: sum of 2 quarters · filed 2017-05-08 | $0.00 derived: sum of 3 quarters · filed 2017-05-08 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |